On Monday, Praxis Precision Medicines Inc (NASDAQ: PRAX) was -4.41% drop from the session before settling in for the closing price of $288.45. A 52-week range for PRAX has been $26.70 – $317.72.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 8.54%. When this article was written, the company’s average yearly earnings per share was at -28.06%. With a float of $25.37 million, this company’s outstanding shares have now reached $27.41 million.
Praxis Precision Medicines Inc (PRAX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Praxis Precision Medicines Inc stocks. The insider ownership of Praxis Precision Medicines Inc is 7.44%, while institutional ownership is 81.79%. The most recent insider transaction that took place on Nov 20 ’25, was worth 4,852,256. In this transaction General Counsel and Secretary of this company sold 25,130 shares at a rate of $193.09, taking the stock ownership to the 20,832 shares. Before that another transaction happened on Nov 20 ’25, when Company’s Principal Accounting Officer sold 13,600 for $192.08, making the entire transaction worth $2,612,244. This insider now owns 10,442 shares in total.
Praxis Precision Medicines Inc (PRAX) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -2.94 earnings per share (EPS) during the time that was less than consensus figure (set at -2.82) by -0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.29% during the next five years compared to 8.54% growth over the previous five years of trading.
Praxis Precision Medicines Inc (NASDAQ: PRAX) Trading Performance Indicators
You can see what Praxis Precision Medicines Inc (PRAX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1013.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.90, a number that is poised to hit -3.09 in the next quarter and is forecasted to reach -12.72 in one year’s time.
